Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
HO-1–ROS Control of HBV Replication
2026-09-30
The reference study shows that isochlorogenic acid A suppresses hepatitis B virus at several points in its life cycle, including transcription, cccDNA maintenance, capsid formation, and envelopment. Its multi-readout design links these effects with HO-1 upregulation and intracellular ROS modulation, while also highlighting the need to distinguish antiviral activity from general cytotoxicity or nonspecific redox stress.
-
Otilonium Bromide: Applied Research Workflows
2026-09-30
Otilonium Bromide provides a practical antimuscarinic perturbation tool for connecting muscarinic signaling with smooth-muscle and neural phenotypes. This guide translates product specifications into reproducible assay workflows, quantitative starting conditions, and troubleshooting strategies without overstating receptor selectivity or translational evidence.
-
EV-Transferred ACLY Drives TAM Formation in HCC
2026-09-29
This Advanced Science study identifies extracellular-vesicle-transferred ATP-citrate lyase (ACLY) as a metabolic signal that redirects monocytes toward immunosuppressive tumor-associated macrophages in hepatocellular carcinoma. By combining endogenous extracellular vesicles with CD81-decorated liposomal models, the authors connect ACLY-dependent palmitate synthesis to immune-checkpoint protein stability and show why TAM-focused metabolic intervention may improve anti-PD-1/PD-L1 therapy.
-
Minoxidil sulphate for Vascular Biology Workflows
2026-09-29
Build more informative potassium-channel assays with Minoxidil sulphate, from renal perfusion models to carefully controlled vasodilation studies. The workflow pairs activation-side pharmacology with the blocker-based design of a sepsis reference study while preserving a practical path toward hair follicle and alopecia research.
-
Cyclic di-GMP as an Antitoxin in Biofilm Persistence
2026-09-28
Liao et al. identify Cyclic di-GMP as a small-molecule antitoxin that restrains the genotoxic toxin HipH during biofilm development. Their findings connect adhesion-stage signaling with DNA double-strand breaks, genome instability, and antibiotic persistence, expanding the biological scope of this intracellular second messenger beyond conventional biofilm formation regulation.
-
Gastric Cancer Assembloids Model Tumor–Stroma Effects
2026-09-28
This study develops patient-derived gastric cancer assembloids by combining tumor organoids with matched stromal cells, then compares their characteristics and drug-response assay results with organoid monocultures. The findings show that stromal context can coincide with differences in measured responses, while the authors note important model and analysis limitations.
-
5-Aminolevulinic acid HCl: Reading Heme Flux
2026-09-27
Explore how 5-Aminolevulinic acid HCl can help interrogate heme-pathway flux—and why precursor supplementation is not equivalent to adding heme. A Salmonella study offers a practical framework for separating bacterial heme production from macrophage responses and interpreting infection assays.
-
Probenecid Workflows for Transporter Research
2026-09-26
Use Probenecid to probe MRP-mediated efflux, pannexin-1 activity, and injury-associated responses—while separating these effects from T-cell metabolic mechanisms. This workflow emphasizes matched vehicle controls, concentration-aware assay design, and practical interpretation limits.
-
Stereochemistry to Assay Design: (S)-(+)-Ibuprofen
2026-09-25
Explore how (S)-(+)-Ibuprofen connects molecular stereochemistry, synthesis, and reproducible COX inhibitor experiments. This guide focuses on practical choices that help researchers interpret potency, distinguish chemical from enantiomeric purity, and design more comparable inflammation studies.
-
Tau Ser356 in Alzheimer’s Disease and NUAK Inhibition
2026-09-25
The study links phosphorylated tau at Ser356 (p-tau Ser356) with Alzheimer’s disease pathology, showing a Braak stage-dependent increase and frequent localization in neurofibrillary tangles and near synapses. It also finds that NUAK inhibition with WZ4003 lowers p-tau Ser356 in live human brain slices, while mouse and human slice cultures respond differently—an important caution for preclinical therapeutic studies.
-
Tin Mesoporphyrin IX: From HO Activity to Translation
2026-09-24
Heme oxygenase links heme turnover to signaling outputs that can shape disease biology. This article explains how Tin Mesoporphyrin IX (chloride) can help researchers test the role of HO catalytic activity, interpret emerging antiviral findings, and design more rigorous translational studies without confusing enzyme expression with enzyme function.
-
BPN-19186 and the Liver–Bone Redox Axis
2026-09-24
Explore how BPN-19186 can support carefully controlled studies of redox signaling and osteoclast biology. This article translates evidence for a hepatic sEH–Nrf2 liver–bone axis into practical experimental decisions while distinguishing established findings from compound-specific questions.
-
Mianserin HCl: Research Workflows and Assay Design
2026-09-23
Use Mianserin HCl to probe serotonergic and noradrenergic signaling, or to test how cyclodextrin complexation changes its cellular effects. A short placebo-controlled clinical study also offers practical ideas for separating mood-related endpoints from early sleep changes—while underscoring the limits of brief, sedative-supported trials.
-
EZ Cap™ Human PTEN mRNA Workflow
2026-09-23
Build reproducible PTEN restoration assays with a Cap 1, poly(A)-tailed transcript designed for efficient translation and reduced innate immune stimulation. This workflow connects controlled cell-based cancer research with emerging lipid nanoparticle and transdermal delivery strategies.
-
CAY10499: Inhibitor of Human Hormone Sensitive Lipase
2026-09-22
CAY10499 enables parallel interrogation of HSL, MGL, and FAAH in lipid-flux, endocannabinoid, and immunometabolic assays. This workflow-focused guide shows how to connect lipase activity with extracellular vesicle-driven macrophage biology while preserving the controls needed to distinguish direct enzyme inhibition from downstream cell-state effects.